Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.00
+0.05 (0.36%)
Apr 29, 2026, 1:43 PM CST

Meribank Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
97.44165.09399.4685.16192.15
Upgrade
Short-Term Investments
131.9--122.794.1
Upgrade
Cash & Short-Term Investments
229.34165.09399.46207.86286.25
Upgrade
Cash Growth
38.92%-58.67%92.18%-27.39%194.21%
Upgrade
Accounts Receivable
187.12158.22128.63146.97147.53
Upgrade
Other Receivables
6.088.826.55.471.63
Upgrade
Receivables
193.21167.04135.13152.44149.17
Upgrade
Inventory
6.4211.246.918.453.6
Upgrade
Prepaid Expenses
40.2749.628.6124.1319.87
Upgrade
Other Current Assets
1.390.340.090.020.11
Upgrade
Total Current Assets
470.63393.31570.19392.9458.99
Upgrade
Property, Plant & Equipment
473.71479.46162.06178.19190.76
Upgrade
Long-Term Investments
39.1359.5759.5625.2244.45
Upgrade
Goodwill
280.08282.182.87--
Upgrade
Other Intangible Assets
548.24584.0931.6910.221.09
Upgrade
Long-Term Deferred Tax Assets
4.263.82.48--
Upgrade
Other Long-Term Assets
1,060879.54233.17239.8252.03
Upgrade
Total Assets
2,8762,6821,062846.33947.32
Upgrade
Accounts Payable
6.9213.0812.327.64.75
Upgrade
Accrued Expenses
60.1763.3150.6345.8444.57
Upgrade
Current Portion of Long-Term Debt
7.467.32---
Upgrade
Current Portion of Leases
126.8370.8519.2321.5818.25
Upgrade
Current Unearned Revenue
22.4727.3317.5614.7612.97
Upgrade
Other Current Liabilities
23.7150.3527.1719.2815.34
Upgrade
Total Current Liabilities
247.55232.23126.91109.0795.87
Upgrade
Long-Term Debt
155.41162.88---
Upgrade
Long-Term Leases
837.96701.7914.8124.2534.73
Upgrade
Long-Term Unearned Revenue
272.52258.41245.7236.52228.14
Upgrade
Long-Term Deferred Tax Liabilities
93.5199.831.380.65-
Upgrade
Other Long-Term Liabilities
9.359.422.022.052.53
Upgrade
Total Liabilities
1,6161,465390.81372.53361.27
Upgrade
Common Stock
959.76879.76709.76627.76627.76
Upgrade
Additional Paid-In Capital
748.27708.27233.2203.24203.74
Upgrade
Retained Earnings
-454.7-373.23-272.2-350.09-247.58
Upgrade
Comprehensive Income & Other
-4.19-9.07-9.04-9.712.12
Upgrade
Total Common Equity
1,2491,206661.73471.2586.05
Upgrade
Minority Interest
10.9611.659.462.59-
Upgrade
Shareholders' Equity
1,2601,217671.2473.79586.05
Upgrade
Total Liabilities & Equity
2,8762,6821,062846.33947.32
Upgrade
Total Debt
1,128942.8434.0445.8352.97
Upgrade
Net Cash (Debt)
-898.33-777.75365.42162.03233.28
Upgrade
Net Cash Growth
--125.53%-30.54%752.06%
Upgrade
Net Cash Per Share
-9.84-9.785.812.583.87
Upgrade
Filing Date Shares Outstanding
95.9887.9870.9862.7862.78
Upgrade
Total Common Shares Outstanding
95.9887.9870.9862.7862.78
Upgrade
Working Capital
223.08161.08443.27283.83363.12
Upgrade
Book Value Per Share
13.0213.719.327.519.34
Upgrade
Tangible Book Value
420.83339.46627.17460.98584.96
Upgrade
Tangible Book Value Per Share
4.383.868.847.349.32
Upgrade
Land
214.7214.741.0841.0841.08
Upgrade
Buildings
107.62107.6253.8453.2352.95
Upgrade
Machinery
103.2396.5776.5661.4562.83
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.